Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-22

FDA Approved: MORPHINE SULFATE — Supplemental Application (Fresenius Kabi, USA LLC)

View source ↗

Summary

FDA approved a supplemental application for Morphine Sulfate submitted by Fresenius Kabi, USA LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)